{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T07:46:24Z","timestamp":1788594384638,"version":"build-2803163510"},"reference-count":58,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2024,1,6]],"date-time":"2024-01-06T00:00:00Z","timestamp":1704499200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea (NRF)","doi-asserted-by":"publisher","award":["2023R1A2C1007759"],"award-info":[{"award-number":["2023R1A2C1007759"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea (NRF)","doi-asserted-by":"publisher","award":["HI23C0860"],"award-info":[{"award-number":["HI23C0860"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute (KHIDI)","doi-asserted-by":"publisher","award":["2023R1A2C1007759"],"award-info":[{"award-number":["2023R1A2C1007759"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute (KHIDI)","doi-asserted-by":"publisher","award":["HI23C0860"],"award-info":[{"award-number":["HI23C0860"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Bleomycin and 5-fluorouracil (5-FU) are widely used in various dermatological disorders. Both drugs are well-recognized as antineoplastic drugs and exert their effect by blocking the cell cycle. Topical and intralesional formulations are available and have been studied in both non-neoplastic and cancerous lesions. However, data comparing the effect of bleomycin and 5-FU in the dermatological disorders are limited. This review outlines the action mechanisms of both drugs and compares their clinical efficacies in a wide range of dermatologic diseases including hypertrophic scar, wart, skin cancer, vascular malformation, hemangioma, and vitiligo, and discusses the overall safety of the drugs. Intralesional bleomycin treatment is effective in hypertrophic scars and warts, but intralesional 5-FU may also be considered since it is cheaper and less painful. Moreover, intralesional 5-FU and bleomycin injection is a viable option for premalignant lesions (i.e., actinic keratosis) and inoperable skin cancers. Both bleomycin and 5-FU have been applied as treatment adjuncts for vitiligo, with 5-FU showing a slightly better outcome. Both agents have a good safety profile, and no serious side effects have been reported following their use in the field of dermatology.<\/jats:p>","DOI":"10.3390\/jcm13020335","type":"journal-article","created":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T05:21:38Z","timestamp":1704691298000},"page":"335","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Clinical Efficacy of 5-Fluorouracil and Bleomycin in Dermatology"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1795-9977","authenticated-orcid":false,"given":"Suyeon","family":"Kim","sequence":"first","affiliation":[{"name":"Department of Dermatology, Incheon St. Mary\u2019s Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2903-9534","authenticated-orcid":false,"given":"Yu Ri","family":"Woo","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Incheon St. Mary\u2019s Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8289-1190","authenticated-orcid":false,"given":"Sang Hyun","family":"Cho","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Incheon St. Mary\u2019s Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong Deuk","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Incheon St. Mary\u2019s Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0576-0474","authenticated-orcid":false,"given":"Hei Sung","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Incheon St. Mary\u2019s Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,1,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.jaad.2020.02.018","article-title":"Efficacy and tolerability of intralesional bleomycin in dermatology: A systematic review","volume":"83","author":"Bik","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_2","first-page":"1299","article-title":"Bleomycin in Dermatology: A Review of Intralesional Applications","volume":"34","author":"Saitta","year":"2008","journal-title":"Dermatol. Surg."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.1097\/DSS.0000000000002879","article-title":"5-Fluorouracil in Dermatology: The Diverse Uses Beyond Malignant and Premalignant Skin Disease","volume":"47","author":"Searle","year":"2021","journal-title":"Dermatol. Surg."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3109\/09546630902789326","article-title":"Clinical applications for topical 5-fluorouracil in the treatment of dermatological disorders","volume":"20","author":"Moore","year":"2009","journal-title":"J. Dermatol. Treat."},{"key":"ref_5","first-page":"351","article-title":"Treatment of vulvar intraepithelial neoplasia (VIN) with local bleomycin","volume":"3","author":"Roberts","year":"1980","journal-title":"Cancer Clin. Trials"},{"key":"ref_6","first-page":"274","article-title":"Intralesional and Laser-Assisted 5-Fluorouracil in Dermatologic Disease: A Systematic Review","volume":"17","author":"Prince","year":"2018","journal-title":"J. Drugs Dermatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1111\/ijd.14092","article-title":"Evaluation of intralesional injection of bleomycin in the treatment of plantar warts: Clinical and dermoscopic evaluation","volume":"57","author":"Barkat","year":"2018","journal-title":"Int. J. Dermatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.1111\/jocd.13390","article-title":"The efficacy of bleomycin for treating keloid and hypertrophic scar: A systematic review and meta-analysis","volume":"19","author":"Kim","year":"2020","journal-title":"J. Cosmet. Dermatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1111\/j.1365-2133.2010.09939.x","article-title":"Low-dose 5-fluorouracil induces cell cycle G2 arrest and apoptosis in keloid fibroblasts","volume":"163","author":"Huang","year":"2010","journal-title":"Br. J. Dermatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bjps.2018.05.052","article-title":"Treatment of keloid scars with intralesional triamcinolone and 5-fluorouracil injections\u2014A randomized controlled trial","volume":"72","author":"Hietanen","year":"2019","journal-title":"J. Plast. Reconstr. Aesthet. Surg."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.burns.2018.08.011","article-title":"Comparison of efficacy and safety of intralesional triamcinolone and combination of triamcinolone with 5-fluorouracil in the treatment of keloids and hypertrophic scars: Randomized control trial","volume":"45","author":"Khalid","year":"2019","journal-title":"Burns"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.asj.2008.11.006","article-title":"Efficacy of Intralesional 5-Fluorouracil and Triamcinolone in the Treatment of Keloids","volume":"29","author":"Davison","year":"2009","journal-title":"Aesthet. Surg. J."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Mozafari, N., Mollaabasi, F., Mansouri, P., and Robati, R.M. (Dermatol. Surg., 2023). The Combined Application of Bleomycin and Triamcinolone for Treating Refractory Keloids, Dermatol. Surg., Epub ahead of print.","DOI":"10.1097\/DSS.0000000000004056"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jdds.2015.07.003","article-title":"Comparative study between intralesional injection of bleomycin and 5-fluorouracil in the treatment of keloids and hypertrophic scars","volume":"20","author":"Kabel","year":"2016","journal-title":"J. Dermatol. Dermatol. Surg."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"262","DOI":"10.4103\/0378-6323.48428","article-title":"Intralesional bleomycin in the treatment of cutaneous warts: A randomized clinical trial comparing it with cryotherapy","volume":"75","author":"Dhar","year":"2009","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"4","DOI":"10.5070\/D362G0G3MJ","article-title":"Compared therapeutic efficacy between intralesional bleomycin and cryotherapy for common warts: A randomized clinical trial","volume":"13","author":"Adalatkhah","year":"2007","journal-title":"Dermatol. Online J."},{"key":"ref_17","first-page":"499","article-title":"Intralesional bleomycin for warts: A review","volume":"5","author":"Lewis","year":"2006","journal-title":"J Drugs Dermatol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1080\/09546634.2019.1688236","article-title":"A comparative study of intralesional injection of Candida albicans antigen, bleomycin and 5-fluorouracil for treatment of plane warts","volume":"32","author":"Hodeib","year":"2021","journal-title":"J. Dermatol. Treat."},{"key":"ref_19","first-page":"656","article-title":"Treatment of common warts with an intralesional mixture of 5-fluorouracil, lidocaine, and epinephrine: A prospective placebo-controlled, double-blind randomized trial","volume":"34","author":"Yazdanfar","year":"2008","journal-title":"Dermatol. Surg."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1468-3083.2004.00984.x","article-title":"Intralesional 5-fluorouracil, lidocaine and epinephrine mixture for the treatment of verrucae: A prospective placebo-controlled, single-blind randomized study","volume":"18","author":"Aydemir","year":"2004","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1365-2230.2006.02105.x","article-title":"Topical 5-fluorouracil has no additional benefit in treating common warts with cryotherapy: A single-centre, double-blind, randomized, placebo-controlled trial","volume":"31","author":"Luk","year":"2006","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/S0190-9622(88)70140-1","article-title":"Therapeutic evaluation for intralesional injection of bleomycin sulfate in 143 resistant warts","volume":"18","author":"Amer","year":"1988","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"21","DOI":"10.5826\/dpc.0703a04","article-title":"Successful treatment of plantar warts with intralesional bleomycin and electroporation: Pilot prospective study","volume":"7","author":"Pasquali","year":"2017","journal-title":"Dermatol. Pract. Concept."},{"key":"ref_24","first-page":"418","article-title":"Topical 5% 5-fluorouracil cream in the treatment of plantar warts: A prospective, randomized, and controlled clinical study","volume":"5","author":"Salk","year":"2006","journal-title":"J. Drugs Dermatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1111\/ijd.12505","article-title":"A comparison of a 5% potassium hydroxide solution with a 5-fluorouracil and salicylic acid combination in the treatment of patients with anogenital warts: A randomized, open-label clinical trial","volume":"53","author":"Koca","year":"2014","journal-title":"Int. J. Dermatol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jaad.2009.12.013","article-title":"Intralesional agents in the management of cutaneous malignancy: A review","volume":"64","author":"Good","year":"2011","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/archderm.140.7.813","article-title":"Effect of a 1-week treatment with 0.5% topical fluorouracil on occurrence of actinic keratosis after cryosurgery: A randomized, vehicle-controlled clinical trial","volume":"140","author":"Jorizzo","year":"2004","journal-title":"Arch. Dermatol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1365-2133.2007.08271.x","article-title":"A randomised study of topical 5% imiquimod vs. topical 5-fluorouracil vs. cryosurgery in immunocompetent patients with actinic keratoses: A comparison of clinical and his-tological outcomes including 1-year follow-up","volume":"157","author":"Krawtchenko","year":"2007","journal-title":"Br. J. Dermatol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/S0149-2918(02)80012-1","article-title":"Evaluation of the efficacy and tolerability of 0.5% fluorouracil cream and 5% fluorouracil cream applied to each side of the face in patients with actinic keratosis","volume":"24","author":"Loven","year":"2002","journal-title":"Clin. Ther."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0190-9622(97)70328-1","article-title":"Nonsurgical treatment of basal cell carcinomas with intralesional 5-fluorouracil\/epinephrine injectable gel","volume":"36","author":"Miller","year":"1997","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0190-9622(97)70178-6","article-title":"Intralesional bleomycin-mediated electrochemotherapy in 20 patients with basal cell carcinoma","volume":"37","author":"Glass","year":"1997","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0188-4409(01)00278-8","article-title":"Electrochemotherapy in Primary and Metastatic Skin Tumors: Phase II Trial Using Intralesional Bleomycin","volume":"32","year":"2001","journal-title":"Arch. Med. Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.abd.2022.09.009","article-title":"Chemotherapeutical treatment of basal cell carcinoma with bleomycin via microinfusion of the drug into the skin (MMP\u00ae)","volume":"98","author":"Pacola","year":"2023","journal-title":"An. Bras. Dermatol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"25","DOI":"10.5070\/D31NW1550F","article-title":"Intralesional bleomycin as alternative therapy in the treatment of multiple basal cell carcinomas","volume":"12","author":"Gyurova","year":"2006","journal-title":"Dermatol. Online J."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1177\/120347540300700201","article-title":"Topical treatment of Bowen\u2019s disease with 5-Fluorouracil","volume":"7","author":"Bargman","year":"2003","journal-title":"J. Cutan. Med. Surg."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1046\/j.1365-2133.2003.05033.x","article-title":"Randomized comparison of photodynamic therapy with topical 5-fluorouracil in Bowen\u2019s disease","volume":"148","author":"Salim","year":"2003","journal-title":"Br. J. Dermatol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.jaad.2015.09.040","article-title":"Intralesional 5-fluorouracil (FU) as a treatment for nonmelanoma skin cancer (NMSC): A review","volume":"74","author":"Metterle","year":"2016","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/j.jaad.2020.12.049","article-title":"Intralesional 5-fluorouracil for the treatment of squamous cell carcinomas","volume":"84","author":"Maxfield","year":"2021","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/ajd.14148","article-title":"Intralesional 5-fluorouracil as a management for cutaneous squamous cell carcinomas: A rural Australian retrospective case series","volume":"64","author":"Luu","year":"2023","journal-title":"Australas. J. Dermatol."},{"key":"ref_40","first-page":"1150","article-title":"Treatment of squamous cell carcinoma with intralesional 5-Fluorouracil","volume":"29","author":"Morse","year":"2003","journal-title":"Dermatol. Surg."},{"key":"ref_41","first-page":"454","article-title":"Treatment of giant keratoacanthoma with intralesional 5-fluorouracil","volume":"5","author":"Leonard","year":"2006","journal-title":"J. Drugs Dermatol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/00008390-200502000-00008","article-title":"Treatment of metastatic mel-anoma using electroporation therapy with bleomycin (electrochemotherapy)","volume":"15","author":"Byrne","year":"2005","journal-title":"Melanoma Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2310\/7750.2006.00037","article-title":"Randomized Controlled Study of Electrochemotherapy in the Local Treatment of Skin Metastases of Melanoma","volume":"10","author":"Gaudy","year":"2006","journal-title":"J. Cutan. Med. Surg."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1001\/archderm.1983.01650330014006","article-title":"Topically Administered Fluorouracil in Vitiligo","volume":"119","author":"Tsuji","year":"1983","journal-title":"Arch. Dermatol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"197","DOI":"10.4103\/JCAS.JCAS_12_20","article-title":"Efficacy of topical 5% 5-fluorouracil with needling versus 5% 5-fluorouracil alone in stable vitiligo: A randomized controlled study","volume":"13","author":"Adil","year":"2020","journal-title":"J. Cutan. Aesthet. Surg."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2147\/CCID.S225881","article-title":"Effect of Topical 5-Fluorouracil Alone versus Its Combination with Erbium:YAG (2940 nm) Laser in Treatment of Vitiligo","volume":"13","author":"Abdelwahab","year":"2020","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1111\/jocd.12820","article-title":"Intradermal injection of Fluorouracil versus triamcinolone in localized vitiligo treatment","volume":"18","author":"Zohdy","year":"2019","journal-title":"J. Cosmet. Dermatol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.ijom.2018.03.024","article-title":"Role of intralesional bleomycin and intralesional triamcinolone therapy in residual haemangioma following propranolol","volume":"47","author":"Pandey","year":"2018","journal-title":"Int. J. Oral Maxillofac. Surg."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/PRS.0000000000001924","article-title":"Intralesional Bleomycin Injections for Vascular Malformations: A Systematic Review and Meta-Analysis","volume":"137","author":"Horbach","year":"2016","journal-title":"Plast. Reconstr. Surg."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"e13083","DOI":"10.1111\/dth.13083","article-title":"Venous malformation of the glans penis successfully treated with intralesional bleomycin injection","volume":"32","author":"Lee","year":"2019","journal-title":"Dermatol Ther."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e572","DOI":"10.1111\/ijd.12586","article-title":"Efficacy of intralesional bleomycin for the treatment of plantar hard corns","volume":"53","author":"Lee","year":"2014","journal-title":"Int. J. Dermatol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1007\/BF02988993","article-title":"Intralesional bleomycin injection in treatment of condyloma acuminatum","volume":"23","author":"Figueroa","year":"1980","journal-title":"Dis. Colon Rectum"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1097\/DSS.0000000000000447","article-title":"Cutaneous Sarcoidosis Successfully Treated with Intralesional 5-Fluorouracil","volume":"41","author":"Gharavi","year":"2015","journal-title":"Dermatol. Surg."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1055\/s-0030-1270415","article-title":"Soft Tissue Fillers and Biofilms","volume":"27","author":"Dayan","year":"2011","journal-title":"Fac. Plast. Surg."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1001\/archderm.1981.01650020031020","article-title":"Topical chemotherapy of dysplastic melanocytic nevi with 5% fluorouracil","volume":"117","author":"Bondi","year":"1981","journal-title":"Arch. Dermatol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1067\/mjd.2000.105563","article-title":"Topical tretinoin and 5-fluorouracil in the treatment of linear verrucous epidermal nevus","volume":"43","author":"Kim","year":"2000","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0190-9622(08)81933-0","article-title":"Management of linear verrucous epidermal nevus with topical 5-fluorouracil and tretinoin","volume":"30","author":"Nelson","year":"1994","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"E19","DOI":"10.12788\/cutis.0697","article-title":"Cutaneous T-Cell Lymphoma Treatment: Case Series of Combination Therapy with Intralesional Injections of 5-Fluorouracil and Topical Imiquimod","volume":"111","author":"Lindberg","year":"2023","journal-title":"Cutis"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/2\/335\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T13:41:26Z","timestamp":1760103686000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/2\/335"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,6]]},"references-count":58,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,1]]}},"alternative-id":["jcm13020335"],"URL":"https:\/\/doi.org\/10.3390\/jcm13020335","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,6]]}}}